Why is Ajooni Biotech falling/rising?

As of 30-Jun, Ajooni Biotech Ltd's stock price is currently at 6.00, reflecting a decrease of 0.02 or 0.33%. Today's performance indicates that the stock has underperformed its sector by 1.02%. Despite being higher than the 5-day, 20-day, and 50-day moving averages, it remains lower than the 100-day and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 65.04% against the 5-day average. While the company has reported positive results for the last three consecutive quarters, including a 49.49% growth in net sales and a record PAT of Rs 1.54 cr, its long-term fundamentals appear weak, as indicated by a low average ROCE of 5.11% and a poor EBIT to Interest ratio of 1.80.
In the broader market context, Ajooni Biotech's short-term return of 7.53% over the past week significantly outpaces the Sensex's return of 2.18%. However, the stock has underperformed year-to-date with a decline of 22.78%, contrasting sharply with the Sensex's gain of 7.92%. Despite generating a return of 14.07% over the past year, which is higher than the market's average return of 3.95%, the stock's long-term performance has been disappointing, with a 3-year decline of 26.47% compared to the Sensex's impressive 61.70% gain. This combination of short-term gains and long-term weaknesses may contribute to the current downward pressure on the stock price.